TY - JOUR
T1 - Prevalence of Ophthalmological Manifestations in Patients with Inborn Errors of Immunity
T2 - A Systematic Review and Meta-Analysis
AU - Zárate-Pinzón, Laura
AU - Mejía-Salgado, Germán
AU - Cifuentes-González, Carlos
AU - Correa-Jiménez, Oscar
AU - Amaris, Stefania
AU - Alfaro-Murillo, Alberto
AU - Téllez-Zambrano, Juanita
AU - Verbel, Angie
AU - Monje-Tobar, Paula
AU - de-la-Torre, Alejandra
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Background: Although some reports indicate ocular involvement in Inborn Errors of Immunity (IEI) patients, the characteristics of this association remain unclear. Increased awareness can facilitate early diagnosis and prevention of visual complications. Objective: To determine the prevalence and characterize ophthalmological manifestations in patients with IEI. Methods: A systematic literature search was performed across Embase, PubMed, and Lilacs. Observational studies with at least 10 IEI patients exhibiting ophthalmological manifestations were reviewed. A meta-analysis using a random effects model, weighted proportion, and 95% confidence intervals were reported as appropriate. Results: Sixty-two articles out of the 6,884 studies were included. The pooled prevalence of ocular manifestations in IEI patients was 54% (95%CI = 39–69), with a mean age of 11.1 ± 7.8 years and male predominance. Regarding the type of IEI with ocular involvement, the most frequently affected group was the Combined immunodeficiencies with associated or syndromic features (82%, 95%CI = 66–91), followed by the diseases of immune dysregulation (73%, 95%CI = 27–95), auto-inflammatory disorders (48%, 95%CI = 10–88), and congenital defects of phagocytes (39%, 95%CI = 11–76). Europe had the highest prevalence of patients with ocular manifestations (68%, 95%CI = 32–90). The most common ocular manifestations observed in IEI patients were those affecting ocular mobility, followed by those that involved the anterior segment, posterior segment, eyelids, and adnexal structures. Conclusions: These results highlight a significant burden of ocular involvement in IEI patients, mainly during childhood and associated with amblyogenic factors. Therefore, ophthalmologists, pediatricians, and immunologists must be involved in early detection to prevent ocular complications and overall well-being.
AB - Background: Although some reports indicate ocular involvement in Inborn Errors of Immunity (IEI) patients, the characteristics of this association remain unclear. Increased awareness can facilitate early diagnosis and prevention of visual complications. Objective: To determine the prevalence and characterize ophthalmological manifestations in patients with IEI. Methods: A systematic literature search was performed across Embase, PubMed, and Lilacs. Observational studies with at least 10 IEI patients exhibiting ophthalmological manifestations were reviewed. A meta-analysis using a random effects model, weighted proportion, and 95% confidence intervals were reported as appropriate. Results: Sixty-two articles out of the 6,884 studies were included. The pooled prevalence of ocular manifestations in IEI patients was 54% (95%CI = 39–69), with a mean age of 11.1 ± 7.8 years and male predominance. Regarding the type of IEI with ocular involvement, the most frequently affected group was the Combined immunodeficiencies with associated or syndromic features (82%, 95%CI = 66–91), followed by the diseases of immune dysregulation (73%, 95%CI = 27–95), auto-inflammatory disorders (48%, 95%CI = 10–88), and congenital defects of phagocytes (39%, 95%CI = 11–76). Europe had the highest prevalence of patients with ocular manifestations (68%, 95%CI = 32–90). The most common ocular manifestations observed in IEI patients were those affecting ocular mobility, followed by those that involved the anterior segment, posterior segment, eyelids, and adnexal structures. Conclusions: These results highlight a significant burden of ocular involvement in IEI patients, mainly during childhood and associated with amblyogenic factors. Therefore, ophthalmologists, pediatricians, and immunologists must be involved in early detection to prevent ocular complications and overall well-being.
UR - http://www.scopus.com/inward/record.url?scp=105004886567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105004886567&partnerID=8YFLogxK
U2 - 10.1007/s10875-025-01880-4
DO - 10.1007/s10875-025-01880-4
M3 - Research Article
C2 - 40358744
AN - SCOPUS:105004886567
SN - 0271-9142
VL - 45
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
IS - 1
M1 - 92
ER -